Hepatitis of unknown aetiology in children – epidemiological overview of cases reported in Europe, 1 January to 16 June 2022
Adriana Romaní Vidal(European Centre for Disease Prevention and Control), Christopher Williams(Public Health Wales), Anders Koch(Statens Serum Institut), Rosa Joosten(National Institute for Public Health and the Environment), Lior Hecht Sagie(Israel Ministry of Health), Ingvild Fjeldheim(Norwegian Institute of Public Health), Michael Peeters(Sciensano (Belgium)), Ana Avellón(Instituto de Salud Carlos III), Piers Mook(World Health Organization Regional Office for Europe), Neil McInnes(NHS Greater Glasgow and Clyde), Eli Heen(Norwegian Institute of Public Health), Carmen Varela(Hospital Universitario Ramón y Cajal), Maureen O’Leary(Public Health Scotland), Conall Watson(London School of Hygiene & Tropical Medicine), Małgorzata Stępień(Narodowy Instytut Zdrowia Publicznego PZH – Państwowy Instytut Badawczy), Emmi Andersson(Public Health Agency of Sweden), Aisling Vaughan(Epidemic Intelligence Service), Aikaterini Mougkou(European Centre for Disease Prevention and Control), Lina Nerlander(European Centre for Disease Prevention and Control), Soledad Colombe(World Health Organization Regional Office for Europe), Claire Neill(Public Health Agency), Cécile Brouard(Santé Publique France), Barbara Suligoi, Anastasia Zisouli(National Public Health Organization), Géraldine De Muylder(Sciensano (Belgium)), Piotr Polański(Narodowy Instytut Zdrowia Publicznego PZH – Państwowy Instytut Badawczy), João Vieira Martins(Direção Geral do Território), Rui Tato Marinho(Villa Maria Hospital), Meera Chand(St Thomas' Hospital), Carlos Carvalho(European Centre for Disease Prevention and Control), Tencho Tenev(Institute of Cancer Research), Kathy Li(MRC University of Glasgow Centre for Virus Research), Annemarie Broderick(National Children’s Research Centre), Veronika Vorobieva Solholm Jensen(Statens Serum Institut), Rivka Rich(Israel Ministry of Health), Sema Mandal, Declan Bradley(Queen's University Belfast), Maria Elena Tosti, Francesco Innocenti(Società Italiana di Medicina Generale), Georgia Nikolopoulou(National Public Health Organization), Laura Coughlan, Julie Figoni(Santé Publique France), Roan Pijnacker(National Institute for Public Health and the Environment), Natalia Rachwal(European Centre for Disease Prevention and Control), Niamh Murphy(Royal Belfast Hospital for Sick Children), B C Ciancio(European Centre for Disease Prevention and Control), Marie Jansson Mörk(Public Health Agency of Sweden), Lital Goldberg(Israel Ministry of Health), Enrique Delgado(European Centre for Disease Prevention and Control), Elitsa Golkocheva‐Markova(National Center of Infectious and Parasitic Diseases)
Cited by 29
Related Papers
Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity
|Cell|2020|1.1k
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
|Cell|2021|656
The developing human connectome project: A minimal processing pipeline for neonatal cortical surface reconstruction
|NeuroImage|2018|543